Genome Testing Market, By Test Type (Carrier Testing, Predictive Testing, Diagnostic Testing, Prenatal & Newborn Testing, Nutrigenomics and Pharmacogenomics), By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV2535
|
Published Date
September 2024
|
Pages
378
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Genome Testing Market size was valued at USD 8,954.2 Million in 2023, expanding at a CAGR of 22.50% from 2024 to 2032.
DNA testing has several medical uses, including infant DNA screening, identity diagnostics and forensics, pre-natal DNA carrier screening, infectious disease diagnostics, oncology histopathology and diagnostics, and so on. Genetic testing involves the use of hair, blood, skin, and other samples. Depending on the suspected ailment, the sample is sent to a lab, where researchers look for specific proteins, DNA, or chromosome changes. Kits and panels are used in DNA testing to detect diseases in humans. Human blood samples are collected for DNA testing, and the tests are performed using test kits and lab equipment.
Genome Testing Market- Market Dynamics
Growing Need for DNA Testing in Various Applications
Diagnostic testing is used to identify or rule out a specific genetic or chromosomal abnormality. When physical signs and symptoms point to a problem, genetic testing is commonly used to confirm the diagnosis. Although diagnostic testing is not available for every gene or genetic condition, it can be performed prior to birth or at any time during an individual\'s life. A diagnostic test\'s results may influence decisions about medical care and disease management. DNA sequences are employed in forensic testing to identify individuals for legal purposes. This testing can be used to establish biological relationships between persons, identify victims of crime or tragedy, exclude or implicate a criminal suspect, and so on.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL GENOME TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Genentech Inc.
Sorenson Genomics, LLC
Abbott Molecular
Bayer Diagnostics
Biocartis
BioHelix
Celera Genomics
Genomic Health
HTG Molecular Diagnostics
PacBio
Others
GLOBAL GENOME TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
Carrier Testing
Predictive Testing
Diagnostic Testing
Prenatal & Newborn Testing
Nutrigenomics
Pharmacogenomics
Others
GLOBAL GENOME TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032
Cancer
Alzheimer’s
Thalassemia
Cystic Fibrosis
Huntington’s Disease
Duchenne Muscular Dystrophy
Other Diseases
GLOBAL GENOME TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Genome Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Genome Testing Market Snippet by Test Type
2.1.2. Genome Testing Market Snippet by Disease
2.1.3. Genome Testing Market Snippet by Country
2.1.4. Genome Testing Market Snippet by Region
2.2. Competitive Insights
3. Genome Testing Key Market Trends
3.1. Genome Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Genome Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Genome Testing Market Opportunities
3.4. Genome Testing Market Future Trends
4. Genome Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Genome Testing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Genome Testing Market Landscape
6.1. Genome Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Genome Testing Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
7.1.2. Carrier Testing
7.1.3. Predictive Testing
7.1.4. Diagnostic Testing
7.1.5. Prenatal & Newborn Testing
7.1.6. Nutrigenomics
7.1.7. Pharmacogenomics
7.1.8. Others
8. Genome Testing Market – By Disease
8.1. Overview
8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
8.1.2. Cancer
8.1.3. Alzheimer’s
8.1.4. Thalassemia
8.1.5. Cystic Fibrosis
8.1.6. Huntington’s Disease
8.1.7. Duchenne Muscular Dystrophy
8.1.8. Other Diseases
9. Genome Testing Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Genome Testing Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Genome Testing Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Genome Testing Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Genome Testing Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Genome Testing Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Genome Testing Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Genentech Inc.
10.2.2. Sorenson Genomics, LLC
10.2.3. Abbott Molecular
10.2.4. Bayer Diagnostics
10.2.5. Biocartis
10.2.6. BioHelix
10.2.7. Celera Genomics
10.2.8. Genomic Health
10.2.9. HTG Molecular Diagnostics
10.2.10. PacBio
10.2.11. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
